Gene therapy developer building in-house cGMP manufacturing and supply
Kriya Therapeutics develops gene therapies for chronic disease, and its stack shows a company running its own production: DeltaV, PI System, SCADA, MES and Tulip sit alongside ddPCR and HPLC analytics. Hiring tilts toward logistics, quality and QC, matching active work on warehousing and electronic batch records for Phase III readiness. A parallel AI track using LangGraph, CrewAI and AWS Bedrock points to agentic and RAG tooling built internally.
Kriya Therapeutics is a privately held biopharmaceutical company founded in 2019 and headquartered in Morrisville, NC. It develops gene therapies targeting chronic diseases, with a pipeline spanning ophthalmology, metabolic disease and neurology. The company has operations in North Carolina's Research Triangle region and in Palo Alto, California. It employs 51–200 people and currently hires within the United States. Business systems include NetSuite, SAP, Oracle, Box and Expensify, while clinical and pharmacometric work relies on tools such as CDISC standards, NONMEM and IVRS.
Kriya uses manufacturing systems like DeltaV, PI System, SCADA, MES and Tulip, lab tools such as HPLC and ddPCR, business apps like NetSuite and SAP, and Python-based AI tooling including LangGraph, CrewAI and AWS Bedrock.
Current initiatives include warehouse improvements for Phase III readiness, an electronic batch record rollout, a frozen drug substance/drug product project, GMP lab equipment validation and agentic AI with RAG pipelines.
Kriya is headquartered in Morrisville, NC, with operations in the Research Triangle area and Palo Alto, California. It has 51–200 employees.
Other companies in the same industry, closest in size
Kriya Therapeutics, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.